US Stock MarketDetailed Quotes

ABVX Abivax S.A.

Watchlist
  • 7.660
  • +0.060+0.79%
Close Dec 26 16:00 ET
  • 7.660
  • 0.0000.00%
Post 16:07 ET
481.98MMarket Cap-2.15P/E (TTM)

Abivax S.A. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Abivax S.A. Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 1.704M--
Nov 7, 20242024/Q3-- / 3.408M--
Sep 9, 20242024/Q2-- / 1.123M--
--2024/Q1-- / 1.123M--
--2019/Q120.000K / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 1.704M--
Nov 7, 20242024/Q3-- / 3.408M--
Sep 9, 20242024/Q2-- / 1.123M--
--2024/Q1-- / 1.123M--
--2019/Q120.000K / 0.000--

Unlock Free Earnings Estimates

Abivax S.A. Earnings Reports

  • Abivax S.A. | 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 9 16:31 ET

  • Abivax S.A. | 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 9 16:11 ET

  • Abivax S.A. | 6-K: Report of foreign private issuer (related to financial reporting)

    Jun 4 16:56 ET

  • Abivax S.A. | 20-F: FY2023 Annual Report

    Apr 5 16:12 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    SilverCrest Metals
    SILV
    +2.40%
    Cars.com
    CARS
    +2.25%
    Lantheus
    LNTH
    +2.14%
    Collegium Pharmaceutical
    COLL
    +1.48%
    Hutchmed (China)
    HCM
    +1.19%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 26, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data